Viewing Study NCT02536495


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-01-29 @ 10:38 PM
Study NCT ID: NCT02536495
Status: WITHDRAWN
Last Update Posted: 2015-10-30
First Post: 2015-08-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer
Sponsor: Erin Bertino
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Squamous Cell Lung Carcinoma View
None Stage IV Squamous Cell Lung Carcinoma View
Keywords: